| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts of the 47th A.I.S.F. – Italian Association for the Study of the Liver – Annual Meeting 2014
|
|
|
2014
|
46 |
S1 |
p. e70-
1 p.
|
artikel
|
| 2 |
A cost-consequence analysis of screening and treatment for chronic hepatitis B (CHB) virus infection in resident immigrants of an Italian North-East
|
Rosa-Rizzotto, E.
|
|
2014
|
46 |
S1 |
p. e23-
1 p.
|
artikel
|
| 3 |
Activation of the developmental pathway Ngn-3/miR-7a regulates cholangiocytes proliferation in response to injury
|
Marzioni, M.
|
|
2014
|
46 |
S1 |
p. e3-
1 p.
|
artikel
|
| 4 |
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: A real life cross-sectional study
|
Morando, F.
|
|
2014
|
46 |
S1 |
p. e33-
1 p.
|
artikel
|
| 5 |
Adult human biliary tree stem cells (hBTSCs) are efficiently reprogrammed to functional insulin-secreting β-pancreatic islet cells by a newly synthesized human Pdx1 peptide
|
Cardinale, V.
|
|
2014
|
46 |
S1 |
p. e4-
1 p.
|
artikel
|
| 6 |
AKIN vs conventional criteria to diagnose pre-liver transplant acute kidney injury: Gender differences and outcome post-LT
|
Fiacco, F.
|
|
2014
|
46 |
S1 |
p. e61-e62
nvt p.
|
artikel
|
| 7 |
Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease
|
Vanni, E.
|
|
2014
|
46 |
S1 |
p. e54-
1 p.
|
artikel
|
| 8 |
Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease
|
Mezzabotta, L.
|
|
2014
|
46 |
S1 |
p. e53-e54
nvt p.
|
artikel
|
| 9 |
Angiogenesis in chronic hepatitis C recurring after liver transplantation is correlated with splancnic hemodinamics
|
Pizzi, M.
|
|
2014
|
46 |
S1 |
p. e67-
1 p.
|
artikel
|
| 10 |
A novel simplified Child-Turcotte-Pugh score for prognostic assessment and therapeutic decision in patients with hepatocellular carcinoma
|
A.Vitale,
|
|
2014
|
46 |
S1 |
p. e5-
1 p.
|
artikel
|
| 11 |
Antagonistic signalling by PPARgamma and rosiglitazone converge on Ruvbl1 regulation in HCC cells
|
Mello, T.
|
|
2014
|
46 |
S1 |
p. e38-
1 p.
|
artikel
|
| 12 |
Appearance of combined hepatocellular cholangiocarcinoma in cirrhosis at contrast enhanced imaging techniques
|
Sagrini, E.
|
|
2014
|
46 |
S1 |
p. e17-
1 p.
|
artikel
|
| 13 |
A regret-based approach to choose between trans-catheter arterial embolization and hepatic resection for intermediate hepatocellular carcinoma
|
Cucchetti, A.
|
|
2014
|
46 |
S1 |
p. e16-
1 p.
|
artikel
|
| 14 |
Association of IFNL4 genotype and ALT decrease is a new tool to predict viral eradication in HCV Sardinian patients with chronic hepatitis C, genotype 4, treated with PEG-IFNα and Ribavirin
|
Chessa, L.
|
|
2014
|
46 |
S1 |
p. e48-e49
nvt p.
|
artikel
|
| 15 |
Barcelona Clinic Liver Cancer staging and the net benefit of liver resection for patients with hepatocellular carcinoma: a multicentre, cohort study
|
Vitale, A.
|
|
2014
|
46 |
S1 |
p. e15-e16
nvt p.
|
artikel
|
| 16 |
Bleeding-unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with β-blockers: A meta-analysis
|
Ferrarese, A.
|
|
2014
|
46 |
S1 |
p. e31-
1 p.
|
artikel
|
| 17 |
Cannabinoid receptor 2-63 Qq variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C
|
Coppola, N.
|
|
2014
|
46 |
S1 |
p. e21-
1 p.
|
artikel
|
| 18 |
Caspase-3 targeting: A further tile sustaining the anti-apoptotic role of miR-221 in hepatocellular carcinoma
|
Fornari, F.
|
|
2014
|
46 |
S1 |
p. e6-
1 p.
|
artikel
|
| 19 |
Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress
|
Ferrigno, A.
|
|
2014
|
46 |
S1 |
p. e27-e28
nvt p.
|
artikel
|
| 20 |
Cholangiocarcinoma (CCA) express chemokine receptor CXCR7: Important role of CXCR7 in mediating CXCL12 induced CCA cells chemotaxis and survival
|
Gentilini, A.
|
|
2014
|
46 |
S1 |
p. e37-
1 p.
|
artikel
|
| 21 |
Chronic hepatitis B patients developing tubular dysfunction during long-term tenofovir treatment can be successfully and safely rescued by entecavir
|
Mangia, G.
|
|
2014
|
46 |
S1 |
p. e24-
1 p.
|
artikel
|
| 22 |
Chronic treatment with betablockers for the management of portal hypertension: A multi-center cross-sectional study in elderly patients with cirrhosis
|
La Mura, V.
|
|
2014
|
46 |
S1 |
p. e32-
1 p.
|
artikel
|
| 23 |
Coffee enhances the expression of mitochondrial and endoplasmic reticulum chaperones in rats with steatohepatitis
|
Salomone, F.
|
|
2014
|
46 |
S1 |
p. e27-
1 p.
|
artikel
|
| 24 |
Concomitant versus sequential treatment with TACE and sorafenib in HCC patients
|
Sacco, R.
|
|
2014
|
46 |
S1 |
p. e37-
1 p.
|
artikel
|
| 25 |
Cost-efficacy analysis of chronic hepatitis B treatment in a real-life setting of the Northern-Italy
|
Pecere, S.
|
|
2014
|
46 |
S1 |
p. e22-e23
nvt p.
|
artikel
|
| 26 |
c-Rel and p27Kip are downstream targets of ERK5 in hepatocellular carcinoma (HCC) in vivo and in vitro
|
Di Maira, G.
|
|
2014
|
46 |
S1 |
p. e37-e38
nvt p.
|
artikel
|
| 27 |
Does the gut microbiota modulate the inflammatory state in cirrhotic host?
|
Di Gregorio, V.
|
|
2014
|
46 |
S1 |
p. e34-
1 p.
|
artikel
|
| 28 |
Does ultra-deep-sequencing in HCV patients treated with boceprevir/telaprevir-based therapy provide an added value in comparison to standard population-sequencing in the detection of resistance?
|
Di Maio, V.C.
|
|
2014
|
46 |
S1 |
p. e47-e48
nvt p.
|
artikel
|
| 29 |
3D-Speckle Tracking Echocardiography in cirrhotic patients: A possible tool for the diagnosis of cirrhotic cardiomyopathy
|
Iacovone, G.
|
|
2014
|
46 |
S1 |
p. e62-
1 p.
|
artikel
|
| 30 |
Dysregulation of microRNA expression in PBMCs from patients with HCV-related malignancies
|
Piluso, A.
|
|
2014
|
46 |
S1 |
p. e15-
1 p.
|
artikel
|
| 31 |
Early menopausal status is associated with the severity of liver fibrosis in Italian patients with non-alcoholic fatty liver disease
|
Petta, S.
|
|
2014
|
46 |
S1 |
p. e25-e26
nvt p.
|
artikel
|
| 32 |
Early prediction of sustained virologic response by HCV Core Ag kinetics in chronic hepatitis C patients treated with Peginterferon plus Ribavirin
|
Ricco, G.
|
|
2014
|
46 |
S1 |
p. e46-
1 p.
|
artikel
|
| 33 |
Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitors
|
Cento, V.
|
|
2014
|
46 |
S1 |
p. e45-
1 p.
|
artikel
|
| 34 |
Early virological response is the main predictors of viral eradication in HCV haemodialysis patients treated with pegylated interferon plus ribavirin
|
Tucci, A.
|
|
2014
|
46 |
S1 |
p. e13-
1 p.
|
artikel
|
| 35 |
Effect of portal vein thrombosis (PVT) on survival after liver transplantation (LT): A meta-analysis
|
Zanetto, A.
|
|
2014
|
46 |
S1 |
p. e67-e68
nvt p.
|
artikel
|
| 36 |
Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease
|
Rosso, C.
|
|
2014
|
46 |
S1 |
p. e54-
1 p.
|
artikel
|
| 37 |
Effects of Non-Selective β-Blockers on hemodynamic and Paracentesis Induced Circulatory Dysfunction in cirrhotics undergoing large volume paracentesis
|
Ferrarese, A.
|
|
2014
|
46 |
S1 |
p. e59-
1 p.
|
artikel
|
| 38 |
Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP survey
|
Bruno, S.
|
|
2014
|
46 |
S1 |
p. e12-
1 p.
|
artikel
|
| 39 |
Eligibility 2: A prospective, observational, multicentre study on outcomes of peg-interferon/ribavirin (Peg-IFN/RBV) in chronic hepatitis C (CHC)
|
Vukotic, R.
|
|
2014
|
46 |
S1 |
p. e45-e46
nvt p.
|
artikel
|
| 40 |
Eligibility 1: A prospective study evaluating HCV patients’ characteristics of eligibility for antiviral therapy in real clinical practice
|
Gamal, N.
|
|
2014
|
46 |
S1 |
p. e46-e47
nvt p.
|
artikel
|
| 41 |
Endocannabinoids and liver cirrhosis: The endocannabinoid-related molecule oleoyl-ethanolamine (OEA) correlates with clinical complications and 1-year survival
|
Baldassarre, M.
|
|
2014
|
46 |
S1 |
p. e33-
1 p.
|
artikel
|
| 42 |
Enhancer of Zeste Homolog 2 (EZH2) expression and activation in in vivo and in vitro non-alcoholic fatty liver disease (NAFLD)
|
Gnani, D.
|
|
2014
|
46 |
S1 |
p. e28-
1 p.
|
artikel
|
| 43 |
Enrichment in novel rare coding variants of Telomerase gene in hepatocellular carcinoma patients with NASH related cirrhosis
|
Donati, B.
|
|
2014
|
46 |
S1 |
p. e14-e15
nvt p.
|
artikel
|
| 44 |
Entecavir effectiveness in naïve and NUC experienced patients: Interim analysis of the ENTAS cohort study of patients with chronic hepatitis B
|
Porro, E.
|
|
2014
|
46 |
S1 |
p. e50-e51
nvt p.
|
artikel
|
| 45 |
Epicardial fat thickness (EAT) in patients with nonalcoholic fatty liver disease (NAFLD) is associated with markers of cardiovascular damage and severity of steatosis
|
Pisano, G.
|
|
2014
|
46 |
S1 |
p. e3-e4
nvt p.
|
artikel
|
| 46 |
Epidemiological evolution of Chronic Hepatitis Delta in Italy. An analysis of the Master-B cohort
|
Brancaccio, G.
|
|
2014
|
46 |
S1 |
p. e12-e13
nvt p.
|
artikel
|
| 47 |
Epigenetic changes associated with the induction of vesicular steatosis in an in vitro cellular model
|
Pediconi, N.
|
|
2014
|
46 |
S1 |
p. e56-
1 p.
|
artikel
|
| 48 |
Epigenetic drugs targeting cccDNA-bound chromatin modifying enzymes silence HBV transcription and inhibit viral replication
|
Palumbo, G.A.
|
|
2014
|
46 |
S1 |
p. e25-
1 p.
|
artikel
|
| 49 |
Evidence of an iperactivation of inflammasome in peripheral blood mononucleated cells of patients with acute on chronic liver failure
|
Gola, E.
|
|
2014
|
46 |
S1 |
p. e61-
1 p.
|
artikel
|
| 50 |
FcγRIIIa shedding from NK cells does not impair antibody-dependent cellular cytotoxicity in chronic HCV infection
|
Oliviero, B.
|
|
2014
|
46 |
S1 |
p. e49-
1 p.
|
artikel
|
| 51 |
First-line treatment of 90 consecutive HCC with drug eluting beads chemoembolization (DEB-TACE)
|
Triolo, M.
|
|
2014
|
46 |
S1 |
p. e64-
1 p.
|
artikel
|
| 52 |
Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis
|
Lampertico, P.
|
|
2014
|
46 |
S1 |
p. e14-
1 p.
|
artikel
|
| 53 |
Genotype 3 and circulating SCCA-IgM are independently associated with histological features of NASH in HCV infected patients
|
Martini, A.
|
|
2014
|
46 |
S1 |
p. e26-
1 p.
|
artikel
|
| 54 |
HAPs hepatitis B virus (HBV) capsid inhibitors prevent HBc interaction with the viral minichromosome and selected host cell genes to inhibits transcription and affect cccDNA stability
|
Belloni, L.
|
|
2014
|
46 |
S1 |
p. e9-
1 p.
|
artikel
|
| 55 |
HBsAg genetic elements critical for immune escape correlates with HBV reactivation upon immunosuppression
|
Salpini, R.
|
|
2014
|
46 |
S1 |
p. e11-
1 p.
|
artikel
|
| 56 |
HBx directly mediates deregulation of several ncRNAs identified by ChIP-Seq experiment
|
Guerrieri, F.
|
|
2014
|
46 |
S1 |
p. e25-
1 p.
|
artikel
|
| 57 |
HCV genotype 1a and 1b: Similarities and differences in clinical features, therapeutic outcome and predictors of response
|
Morisco, F.
|
|
2014
|
46 |
S1 |
p. e44-
1 p.
|
artikel
|
| 58 |
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: A 3-years follow-up study
|
Basso, M.
|
|
2014
|
46 |
S1 |
p. e48-
1 p.
|
artikel
|
| 59 |
Hemostatic status and portal vein thrombosis (PVT) in cirrhotic patients with hepatocellular carcinoma (HCC)
|
Zanetto, A.
|
|
2014
|
46 |
S1 |
p. e36-
1 p.
|
artikel
|
| 60 |
Hepatitis B virus screening in healthy immigrants: A strategy to prevent the spread of infection and to identify and manage chronic hepatitis B (CHB)
|
Peraro, L.
|
|
2014
|
46 |
S1 |
p. e52-
1 p.
|
artikel
|
| 61 |
Hepatitis C virus in healthy immigrants: To screen or not to screen?
|
Peraro, L.
|
|
2014
|
46 |
S1 |
p. e18-e19
nvt p.
|
artikel
|
| 62 |
High donor-age vs High MELD in liver Tx. Which is the most effective approach? Evidences from the Italy-US D-MELD study
|
Avolio, A.W.
|
|
2014
|
46 |
S1 |
p. e7-e8
nvt p.
|
artikel
|
| 63 |
High rates of tenofovir dose adjustments are required in Adefovir experienced patients with chronic hepatitis B: A 4-year prospective study in 320 patients
|
Lampertico, P.
|
|
2014
|
46 |
S1 |
p. e49-
1 p.
|
artikel
|
| 64 |
Human biliary tree stem/progenitor cells (hBTSCs) from peribiliary glands (PBGs) of adult liver display immunomodulatory properties through Fas/Fas ligand induced T-cell lymphocyte apoptosis
|
Carnevale, G.
|
|
2014
|
46 |
S1 |
p. e30-
1 p.
|
artikel
|
| 65 |
Human cholangiocarcinoma (CCA) and CCA cancer stem cells (CSCs) are highly sensitive to the antiproliferative effects of PI3-kinase inhibitors
|
Fraveto, A.
|
|
2014
|
46 |
S1 |
p. e2-
1 p.
|
artikel
|
| 66 |
Immuno-modulating effects of Silibinin in liver transplant patients with HCV recurrence
|
Castellaneta, A.
|
|
2014
|
46 |
S1 |
p. e67-
1 p.
|
artikel
|
| 67 |
Impact of mTOR inhibition on expression of immune regulatory molecules by circulating dendritic cells and regulatory T cells in stable liver transplant patients
|
Castellaneta, A.
|
|
2014
|
46 |
S1 |
p. e8-
1 p.
|
artikel
|
| 68 |
Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers
|
Cazzagon, N.
|
|
2014
|
46 |
S1 |
p. e29-
1 p.
|
artikel
|
| 69 |
Inhibition of indoleamine 2,3-dioxygenase ameliorates inflammation and fibrosis in experimental steatohepatitis
|
Vivoli, E.
|
|
2014
|
46 |
S1 |
p. e29-
1 p.
|
artikel
|
| 70 |
Inosine triphosphatase deficiency does not predict anemia severity nor anemia management in patients with advanced fibrosis receiving telaprevir
|
Grassi, E.
|
|
2014
|
46 |
S1 |
p. e20-
1 p.
|
artikel
|
| 71 |
Intraoperative histological ischemia–reperfusion injury assessment but not clinical early allograft dysfunction predicts graft loss only in HCV positive recipients submitted to liver transplant
|
Ginanni Corradini, S.
|
|
2014
|
46 |
S1 |
p. e39-
1 p.
|
artikel
|
| 72 |
Ischemia modified albumin (IMA) for the diagnosis of bacterial infection in hospitalized patients with cirrhosis
|
Giannone, F.A.
|
|
2014
|
46 |
S1 |
p. e32-
1 p.
|
artikel
|
| 73 |
Is the vasopressin release the crucial factor in the pathogenesis of hypervolemic hyponatremia in patients with cirrhosis and ascites?
|
Piano, S.
|
|
2014
|
46 |
S1 |
p. e60-
1 p.
|
artikel
|
| 74 |
Italian survey on HBV and liver transplantation in a cohort of 2260 patients
|
Fasulo, R.
|
|
2014
|
46 |
S1 |
p. e8-e9
nvt p.
|
artikel
|
| 75 |
Key genetic markers in the full-length HBsAg gene correlate with HBV-driven carcinogenesis by affecting HBsAg secretion and release
|
Svicher, V.
|
|
2014
|
46 |
S1 |
p. e53-
1 p.
|
artikel
|
| 76 |
Leukaemia inhibitory factor protects cholangiocarcinoma cells from cytotoxicity via a STAT-3-independent, Mcl-1 activation
|
Morton, S.D.
|
|
2014
|
46 |
S1 |
p. e65-
1 p.
|
artikel
|
| 77 |
Linkage between interferon-λ4 and IL28B polymorphisms in HCV-4 patients treated with pegylated interferon and ribavirin
|
De Nicola, S.
|
|
2014
|
46 |
S1 |
p. e21-
1 p.
|
artikel
|
| 78 |
Liver investigation: A possible new tool for cardiovascular risk evaluation
|
Viscomi, C.
|
|
2014
|
46 |
S1 |
p. e56-e57
nvt p.
|
artikel
|
| 79 |
Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A case match analysis
|
Gringeri, E.
|
|
2014
|
46 |
S1 |
p. e39-
1 p.
|
artikel
|
| 80 |
Liver transplantation in cirrhotic patients with portal vein thrombosis: A single centre experience
|
Risso, A.
|
|
2014
|
46 |
S1 |
p. e40-
1 p.
|
artikel
|
| 81 |
Long term NUC treatment in hepatitis B virus HBeAg negative genotype D patients and risk for hepatocellular carcinoma: Evidence from the CLEO cohort study
|
Pellicelli, A.M.
|
|
2014
|
46 |
S1 |
p. e24-
1 p.
|
artikel
|
| 82 |
Long-term outcome of inactive and low viremic HBeAg negative active carriers: Benign one direction transition towards spontaneous HBsAg clearance
|
Surace, L.
|
|
2014
|
46 |
S1 |
p. e13-
1 p.
|
artikel
|
| 83 |
Low accuracy of non-invasive tests for assessing residual cirrhosis in hepatitis C patients with a sustained virological response
|
Degasperi, E.
|
|
2014
|
46 |
S1 |
p. e16-
1 p.
|
artikel
|
| 84 |
Low risk of hepatitis B virus reactivation in HBsAg negative, anti-HBc positive carriers undergoing rituximab for rheumatoid arthritis
|
Viganò, M.
|
|
2014
|
46 |
S1 |
p. e23-
1 p.
|
artikel
|
| 85 |
Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation
|
Minutolo, A.
|
|
2014
|
46 |
S1 |
p. e22-
1 p.
|
artikel
|
| 86 |
Lysosomes involvement in chemoresistance of hepatocellular carcinoma cells
|
Trombetta, E.
|
|
2014
|
46 |
S1 |
p. e65-e66
nvt p.
|
artikel
|
| 87 |
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis
|
Cortesi, P.A.
|
|
2014
|
46 |
S1 |
p. e11-
1 p.
|
artikel
|
| 88 |
Management of infectious mixed cryoglobulinemia: Clinical outcome of 246 patients
|
Mauro, E.
|
|
2014
|
46 |
S1 |
p. e18-
1 p.
|
artikel
|
| 89 |
Marginal liver grafts characterization: (1) Imaging and in situ spectral analysis of Nile Red-induced lipid fluorescence in MCD-induced liver steatosis
|
Tarantola, E.
|
|
2014
|
46 |
S1 |
p. e55-
1 p.
|
artikel
|
| 90 |
Marginal liver grafts characterization: (2) In situ evaluation of oxidative stress in liver steatosis induced by MCD
|
Boncompagni, E.
|
|
2014
|
46 |
S1 |
p. e56-
1 p.
|
artikel
|
| 91 |
MERTK rs4374383 AA genotype is associated with a lower prevalence of severe hepatic steatosis in non-alcoholic fatty liver disease
|
Petta, S.
|
|
2014
|
46 |
S1 |
p. e2-
1 p.
|
artikel
|
| 92 |
Microinvasive intraoperative ultrasound pattern in predicting outcomes for single small (<3cm) hepatocellular carcinoma
|
Santambrogio, R.
|
|
2014
|
46 |
S1 |
p. e66-
1 p.
|
artikel
|
| 93 |
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells
|
Paternostro, C.
|
|
2014
|
46 |
S1 |
p. e1-
1 p.
|
artikel
|
| 94 |
Missense variant in interferon-λ4 gene identifies HCV-1 infected patients carrying the unfavorable IL28B (T) allele with improved viral kinetics
|
Galmozzi, E.
|
|
2014
|
46 |
S1 |
p. e22-
1 p.
|
artikel
|
| 95 |
Mortality prediction with transient elastography after liver transplantation for liver failure of various aetiologies
|
Sagrini, E.
|
|
2014
|
46 |
S1 |
p. e58-
1 p.
|
artikel
|
| 96 |
Non-Invasive Score system for Fibrosis (NISF): A new staging model combining biochemical, elastographic and ultrasound data in chronic liver disease
|
Campion, D.
|
|
2014
|
46 |
S1 |
p. e3-
1 p.
|
artikel
|
| 97 |
NOX2-generated oxidative stress is increased in patients with non-alcoholic fatty liver disease independently from metabolic syndrome
|
Baratta, F.
|
|
2014
|
46 |
S1 |
p. e27-
1 p.
|
artikel
|
| 98 |
Obstructive sleep apnea syndrome in non-severely obese patients with NAFLD
|
Pulixi, E.A.
|
|
2014
|
46 |
S1 |
p. e55-
1 p.
|
artikel
|
| 99 |
Optimizing results of liver transplantation with graft from HBcAb positive donor
|
Tandoi, F.
|
|
2014
|
46 |
S1 |
p. e40-
1 p.
|
artikel
|
| 100 |
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study)
|
Okolicsanyi, S.
|
|
2014
|
46 |
S1 |
p. e7-
1 p.
|
artikel
|
| 101 |
Oxygen gradient on a chip for optimizing the differentiation of human pluripotent stem cells into hepatic cells
|
Tonon, F.
|
|
2014
|
46 |
S1 |
p. e42-
1 p.
|
artikel
|
| 102 |
PAF-receptor antagonists reduce HCC progression blocking cancer cell proliferation and migration
|
Tarocchi, M.
|
|
2014
|
46 |
S1 |
p. e66-
1 p.
|
artikel
|
| 103 |
Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: Is vasopressin (ADH) the only agent to blame?
|
Sansoè, G.
|
|
2014
|
46 |
S1 |
p. e34-e35
nvt p.
|
artikel
|
| 104 |
Peg-interferon and ribavirin therapy is safe and effective among HCV patients with thalassaemia major
|
D’Ambrosio, R.
|
|
2014
|
46 |
S1 |
p. e19-
1 p.
|
artikel
|
| 105 |
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: A meta-analysis on role of response predictors
|
Coppola, N.
|
|
2014
|
46 |
S1 |
p. e19-e20
nvt p.
|
artikel
|
| 106 |
Pharmacokinetics of sunitinib in patients with liver cirrhosis and hepatocellular carcinoma
|
Biolato, M.
|
|
2014
|
46 |
S1 |
p. e64-e65
nvt p.
|
artikel
|
| 107 |
PNPLA3 rs738409 C>G SNP is associated with histological features of NASH in genotype 1 chronic hepatitis C patients
|
Petta, S.
|
|
2014
|
46 |
S1 |
p. e19-
1 p.
|
artikel
|
| 108 |
Point quantification elastography as a noninvasive technique for quantification of liver fibrosis
|
Fiorini, E.
|
|
2014
|
46 |
S1 |
p. e58-e59
nvt p.
|
artikel
|
| 109 |
Polycomb protein enhancer of Zeste Homolog 2 (EZH2) protects human hepatocellular carcinoma (HCC) cells from DNA damage response (DDR) associated apoptosis
|
Salerno, D.
|
|
2014
|
46 |
S1 |
p. e38-
1 p.
|
artikel
|
| 110 |
Portal hypertension but not HCC risk is attenuated in compensated cirrhotics following 10 years of treatment with nucleos(t)ide analogs
|
Invernizzi, F.
|
|
2014
|
46 |
S1 |
p. e50-
1 p.
|
artikel
|
| 111 |
Post sorafenib survival in patients with advanced hepatocellular carcinoma: The role of tumor progression and liver impairment
|
Iavarone, M.
|
|
2014
|
46 |
S1 |
p. e35-e36
nvt p.
|
artikel
|
| 112 |
Prediction of EVS presence by calculated risk scores in B—Viral cirrhosis
|
Marietti, M.
|
|
2014
|
46 |
S1 |
p. e60-
1 p.
|
artikel
|
| 113 |
Pregnancy and primary biliary cirrhosis: A case–control study
|
Franceschet, I.
|
|
2014
|
46 |
S1 |
p. e57-
1 p.
|
artikel
|
| 114 |
Preliminary experience of treatment with Teriparatide of post-OLT severe osteoporosis unresponsive to standard therapy
|
Valente, G.
|
|
2014
|
46 |
S1 |
p. e68-
1 p.
|
artikel
|
| 115 |
Progression of early atherosclerotic vascular damage in patients with NAFLD and in controls of general population during 10 years of follow up
|
Porzio, M.
|
|
2014
|
46 |
S1 |
p. e26-
1 p.
|
artikel
|
| 116 |
PRO-inflammatory and pro-fibrogenic actions of the HIV-envelope protein gp120 are mediated by inflammasome activation and MIR29B
|
Cappon, A.
|
|
2014
|
46 |
S1 |
p. e1-e2
nvt p.
|
artikel
|
| 117 |
Prophylaxis strategy to prevent HBV-reactivation in oncologic immunosuppressed patients: Results of guidelines-based on-field practice
|
Sangiovanni, L.
|
|
2014
|
46 |
S1 |
p. e51-
1 p.
|
artikel
|
| 118 |
P53 status affects copper homeostasis in experimental model of hepatic steatosis
|
Arciello, M.
|
|
2014
|
46 |
S1 |
p. e28-e29
nvt p.
|
artikel
|
| 119 |
Quantification of fibrosis in chronic hepatitis C: Performance of Transient Elastography and Acoustic Radiation Force Impulse using Collagen Proportionate Area as reference
|
Calvaruso, V.
|
|
2014
|
46 |
S1 |
p. e58-
1 p.
|
artikel
|
| 120 |
Reactivation of hepatitis B virus in HBsAg-negative HBcAb-positive patients with psoriasis undergoing immunosuppressive therapy
|
Morisco, F.
|
|
2014
|
46 |
S1 |
p. e51-
1 p.
|
artikel
|
| 121 |
Recipient and donor gender match predicts the outcome of antiviral therapy for recurrent hepatitis C
|
Bitetto, D.
|
|
2014
|
46 |
S1 |
p. e41-
1 p.
|
artikel
|
| 122 |
Reinfusion of highly purified CD133+ stem cells in patients with End-Stage Liver Disease (ESLD): Final results of a phase I clinical trial
|
Margini, C.
|
|
2014
|
46 |
S1 |
p. e6-e7
nvt p.
|
artikel
|
| 123 |
Renal effects of different doses of α2-adrenergic agonists, alone or in combination with diuretics, in rats with experimental cirrhosis and ascites
|
Sansoè, G.
|
|
2014
|
46 |
S1 |
p. e62-
1 p.
|
artikel
|
| 124 |
Resistance to thrombomodulin is associated with de novo portal vein thrombosis and could be a modifiable factor to improve prognosis in cirrhosis
|
La Mura, V.
|
|
2014
|
46 |
S1 |
p. e31-
1 p.
|
artikel
|
| 125 |
Results of surgical treatment of hepatocellular carcinoma in patients with metabolic syndrome as unique oncological risk factor
|
Ajani, C.
|
|
2014
|
46 |
S1 |
p. e35-
1 p.
|
artikel
|
| 126 |
Role of sialic-acid-binding immunoglobulin-like lectin-7 (siglec-7) as biomarker of liver disease severity in chronic HCV infection
|
Varchetta, S.
|
|
2014
|
46 |
S1 |
p. e10-
1 p.
|
artikel
|
| 127 |
SCCA-IgM is predictive of hepatocellular carcinoma development in patients with HCV cirrhosis—A prospective study
|
Biasiolo, A.
|
|
2014
|
46 |
S1 |
p. e61-
1 p.
|
artikel
|
| 128 |
Sex hormones differently regulate hepatic hepcidin expression and systemic iron homeostasis in vivo
|
Garuti, C.
|
|
2014
|
46 |
S1 |
p. e30-
1 p.
|
artikel
|
| 129 |
SIRT1 activity in hepatic stellate cells during liver injury is a target for the modulation of the fibrogenic process
|
Tarocchi, M.
|
|
2014
|
46 |
S1 |
p. e30-e31
nvt p.
|
artikel
|
| 130 |
Sorafenib versus Y90-Radioembolization: A preliminary assessment of tolerability and survival in advanced mono-lobar hepatocellular carcinoma
|
Cantamessa, A.
|
|
2014
|
46 |
S1 |
p. e64-
1 p.
|
artikel
|
| 131 |
Spleen stiffness measurement by ARFI strongly predict the oesophageal varices stage and bleeding probability
|
Bramuzzo, I.
|
|
2014
|
46 |
S1 |
p. e60-
1 p.
|
artikel
|
| 132 |
Stem cell niche and macrophages in human cholangiocarcinoma
|
Raggi, C.
|
|
2014
|
46 |
S1 |
p. e4-
1 p.
|
artikel
|
| 133 |
SVR is associated with no risk reduction of HCC development in patients with HCV-related cirrhosis. A prospective, up-to 23 years, cohort follow-up study
|
De Lisi, S.
|
|
2014
|
46 |
S1 |
p. e33-e34
nvt p.
|
artikel
|
| 134 |
Symptomatic onset identifies a more aggressive subset of primary biliary cirrhosis
|
Quarneti, C.
|
|
2014
|
46 |
S1 |
p. e5-
1 p.
|
artikel
|
| 135 |
The AMPK-related kinase, Nuak2 is modulated by the activation process and regulates motility of hepatic stellate cells (HSC)
|
Guerra, C. Tosti
|
|
2014
|
46 |
S1 |
p. e59-
1 p.
|
artikel
|
| 136 |
The changing scenario of hepatocellular carcinoma in Italy: An update
|
Lenzi, B.
|
|
2014
|
46 |
S1 |
p. e63-
1 p.
|
artikel
|
| 137 |
The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia
|
De Nicolò, A.
|
|
2014
|
46 |
S1 |
p. e10-
1 p.
|
artikel
|
| 138 |
The histological or ultrasonographic detection of steatosis affects the performance of LSM in patients with chronic HCV genotype 1 infection
|
Macaluso, F.S.
|
|
2014
|
46 |
S1 |
p. e20-
1 p.
|
artikel
|
| 139 |
The impact of IL-28B polymorphism and diabetes on SVR after antiviral therapy (AT) for post-liver transplant (LT) HCV recurrence
|
Bitetto, D.
|
|
2014
|
46 |
S1 |
p. e41-
1 p.
|
artikel
|
| 140 |
The inflammasome pathway as a target of berberine in experimental steatohepatitis and acetaminophen toxicity
|
Vivoli, E.
|
|
2014
|
46 |
S1 |
p. e69-
1 p.
|
artikel
|
| 141 |
The predictive role of Week 8 (RVRw8) viral kinetics in prior PR null responders receiving telaprevir in the delayed-start arm of the REALIZE trial
|
Rumi, M.G.
|
|
2014
|
46 |
S1 |
p. e43-
1 p.
|
artikel
|
| 142 |
The red cell distribution width (RDW) is a novel powerful, inexpensive predictor of survival for patients who present with hepatocellular carcinoma
|
Grossi, G.
|
|
2014
|
46 |
S1 |
p. e36-
1 p.
|
artikel
|
| 143 |
Thrombelastography (TEG) decreases blood products requirement before invasive procedures in cirrhotic patients with coagulation tests derangement. A randomized controlled trial
|
De Pietri, L.
|
|
2014
|
46 |
S1 |
p. e5-e6
nvt p.
|
artikel
|
| 144 |
Tumorigenic potential of cancer stem cells (CSCs) isolated from human cholangiocarcinoma (CCA) subtypes
|
Torrice, A.
|
|
2014
|
46 |
S1 |
p. e57-
1 p.
|
artikel
|
| 145 |
Usefulness of Acoustic Radiation Force Impulse (ARFI) in the assessment of liver fibrosis due to recurrent hepatitis C after liver transplantation
|
Dissegna, D.
|
|
2014
|
46 |
S1 |
p. e68-
1 p.
|
artikel
|
| 146 |
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study)
|
Okolicsanyi, S.
|
|
2014
|
46 |
S1 |
p. e63-
1 p.
|
artikel
|
| 147 |
Vitamin E as therapy for children with E antigen positive chronic hepatitis B: Results of a randomized controlled trial
|
Fiorino, S.
|
|
2014
|
46 |
S1 |
p. e52-
1 p.
|
artikel
|
Tijdschrift beschrijving